Skin cancer screening by dermatologists: Prevalence and barriers

Journal of the American Academy of Dermatology

Volumn 46, Issue 5, 2002, Pages 710-714

  Federman, Daniel G ^a,b   Kravetz, Jeffrey D ^a,b   Kirsner, Robert S ^c  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; CLINICAL PRACTICE; DERMATOLOGIST; DERMATOLOGY; EPILUMINESCENCE MICROSCOPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SKIN CANCER;

EID: 0036587121     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120531     Document Type: Article

References (17)

1. Marks R. An overview of skin cancers: incidence and causation. Cancer 1995;75(Suppl):607-12.
2. Rigel DS, Friedman RJ, Kopf AW. Lifetime risk of development of skin cancer in the US population: current estimate is now 1 in 5. J Am Acad Dermatol 1996;35:1012-3.
3. Rigel DS, Kopf AW, Friedman RJ. The rate of malignant melanoma in the United States: are we making an impact? J Am Acad Dermatol 1987;17:1050-3.
4. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996;34:839-47.
5. MacKie RM, Hole D, Hunter JA, Rankin R, Evans A, McLaren K, et al. Cutaneous malignant melanoma in Scotland: incidence, survival and morality 1979-1994. The Scottish Melanoma Group. BMJ 1997;315:1117-21.
6. Pehamberger H, Binder M, Steiner A, Wolff K. In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma. J Invest Dermatol 1993;100:356S-62S.
7. Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol 1987;17:571-83.
8. Steiner A, Binder M, Schemper M, Wolff K, Pehamberger H. Statistical evaluation of epiluminescence microscopy criteria for melanocytic pigmented skin lesions. J Am Acad Dermatol 1993;29:581-8.
9. Steiner A, Pehamberger H, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma. J Am Acad Dermatol 1987:17:584-91.
10. American Cancer Society. Guidelines for the cancer-related checkup: an update. Atlanta: American Cancer Society; 1993.
11. Canadian Task Force on the Periodic Health Examination. Canadian guide to clinical preventive health care. Ottawa, Ontario: Canada Communication Group; 1994. p. 850-61.
12. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams & Wilkins; 1996.
13. Goldsmith LA, Koh HK, Bewerse BA, Reilly B, Wyatt SW, Bergfeld WF, et al. Full proceedings from the National Conference to Develop a National Skin Cancer Agenda. J Am Acad Dermatol 1996; 35:748-56.
14. Federman DG, Concato J, Caralis PV, Hunkele GE, Kirsner RS. Screening for skin cancer in primary care settings. Arch Dermatol 1997;133:1423-5.
15. Kirsner RS, Muhkerjee S, Federman DG. Skin cancer screening in primary care: prevalence and barriers. J Am Acad Dermatol 1999;41:564-6.
16. Polster AM, Laseck RJ, Quinn LM, Chren M. Reports by patients and dermatologists of skin cancer preventive services provided in dermatology offices. Arch Dermatol 1998;134:1095-8.
17. Boyce JA, Bernhard JD.Total skin examination: patient reactions [letter]. J Am Acad Dermatol 1986;14:280.